2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl Ethylxanthate-13C6

CAS: 13639-54-8

Ref. TR-T280302

Produktinformation

• Name: 2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl Ethylxanthate-13C6
• Synonyme: (2R,3R,4S,5R,6S)-2-(acetoxymethyl)-6-((ethoxycarbonothioyl)thio)tetrahydro-2H-pyran-3,4,5-triyl-13C6 triacetate, 2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl Ethylxanthogenate, 2,3,4,6-Tetra-O-acetyl-β-D-glucose ethylxanthat, 2,3,4,6-tetra-O-acetyl-1-S-(ethoxycarbonothioyl)-1-thio-beta-D-glucopyranose, 2,3,4,6-tetra-O-acetyl-1-S-(ethoxycarbothioyl)-1-thiohexopyranose, Glucopyranose, 1-thio-, 2,3,4,6-tetraacetate 1-(O-ethyl dithiocarbonate), β-<span class="text-smallcaps">D</span>-, NSC 66060, β-<span class="text-smallcaps">D</span>-Glucopyranose, 1-thio-, 2,3,4,6-tetraacetate 1-(O-ethyl carbonodithioate), Glucopyranose, 1-thio-, 2,3,4,6-tetraacetate 1-(O-ethyl dithiocarbonate), β-D-, β-D-Glucopyranose, 1-thio-, 2,3,4,6-tetraacetate 1-(O-ethyl carbonodithioate)

Beschreibung

Applications 2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl Ethylxanthate-13C6 is an intermediate in synthesizing Aurothioglucose-13C6 (A794792), a labelled analogue of Aurothioglucose (A794790), which is used in the treatment of rheumatoid arthritis and psoriasis.
References Solomon, D. et al.: J. Am. Med. Assoc., 305, 2525 (2011); Madeira, J. et al.: Inflammopharm., 297, 20 (2012)

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 458.45
• Formel: C₁₁C₆H₂₄O₁₀S₂
• Farbe/Form: Neat
• InChl: InChI=1S/C17H24O10S2/c1-6-22-17(28)29-16-15(26-11(5)21)14(25-10(4)20)13(24-9(3)19)12(27-16)7-23-8(2)18/h12-16H,6-7H2,1-5H3/t12-,13-,14+,15-,16+/m1/s1/i7+1,12+1,13+1,14+1,15+1,16+1
• InChI Key: InChIKey=NAQWICRLNQSPPW-UHFFFAOYSA-N
• SMILES: Clc1c(Cl)c(Cl)c2ccccc2c1Cl